Valeant Faces Default Amid Looming Debt
Valeant Pharmaceuticals International Inc. received a notice of default from bondholders that will become effective if it doesn't file its delayed annual report soon, the Canadian drugmaker announced Tuesday, adding to...To view the full article, register now.
Already a subscriber? Click here to view full article